Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Reliq Health Technologies Inc V.RHT

Alternate Symbol(s):  RQHTF

Reliq Health Technologies Inc. is a Canada-based global healthcare technology company that specializes in developing virtual care solutions. The Company's target markets include virtual care, long-term care and big data. iUGO Care, the Company's platform, is a software as a service solution that supports care coordination and community-based healthcare. The iUGO Care platform integrates wearables, sensors, voice technology and mobile apps and desktop user interfaces for patients, clinicians and healthcare administrators. The iUGO Care platform provides services, such as remote patient monitoring, chronic care management, principal care management, behavioral health integration, telemedicine, transitional care management, remote therapeutic monitoring and wound care. Its behavioral health integration service supports patients with any mental, behavioral, or psychiatric health diagnoses by integrating mental health, psychiatric care, counseling, and addiction services with primary care.


TSXV:RHT - Post by User

Comment by theinvestor22on Apr 17, 2023 2:48pm
208 Views
Post# 35398966

RE:RE:The Disconnect

RE:RE:The Disconnect
longerterm1, first let's deal with the easy stuff.  I'm not and don't intend to be a stock guru.  Yes, I've made millions in the markets, but I've hardly put in much effort and a lot of it was admittedly good fortune.  Also, I've had some spectacular failures, which occasionally get pointed out to me.
 
Moving on the the important stuff, my posting was not intended to deal with actuals, but rather, with the impression that some have given that all the potential for the stock is already built into the stock price.  (BTW, I literally said that in the first paragraph of my posting.)
 
But, you raised the subject of "actuals", which of course are important, even though investing in the present is all about the future.  So, let's look at "actuals", keeping in mind that the company's fiscal year end is June 30th.
 
Most of this is from my notes.
  
Revenue since the corporate reset...
 
f2019 (whole year)   $0.18M
f2020 (whole year)   $1.14M
f2021 (whole year)   $1.46M
f2022 (whole year)   $8.55M
f2023 (first 6 months only)    $7.59M
 
Here are the gross margin percentages since the reset...
 
f2019 (whole year)     4.3%
f2020 (whole year)   15.3%
f2021 (whole year)   58.7%
f2022 (whole year)   62.0%
f2023 (first 6 months only)   62.4%
 
And, finally, pre-tax profit/(loss) excluding one-time items, like forex, etc....
 
f2019 (whole year)   $(13.45M)
f2020 (whole year)   $(11.26M)
f2021 (whole year)   $(11.68M)
f2022 (whole year)   $(8.25M)
f2023 (first 6 months)   $(0.51M) with fQ2 being +$0.14M
 
Taken as a whole, that's pretty impressive "actual" progress.
 
Now, we all know they've had issues relating to adherence and collections.  IMHO, they've made progress on those and I would suggest anyone examining the company watch the investor update webinar published 12 April 2023 (last week) for details on what they're doing to work out the kinks.
 
Let's move on to valuation.  (Note: for the following, I've used the price on the day of each earnings release, revenue as supplied by the company in a couple of MD&As, annualized quarterly results and the basic share count.)
 
When Q2 f2021 results were announced, the price/revenue multiple was about $0.89 stock price / ($418k rev x 4 Qs / 147,475 sh) = 78.5
 
When Q2 f2022 results were announced, the price/revenue multiple was about $0.95 stock price / ($2,140k rev x 4 Qs / 182,761 sh) = 20.3
 
When Q2 f2023 results were announced, the price/revenue multiple was about $0.54 stock price / ($4,119 rev x 4 Qs / 195,759 sh) = 6.4
 
Since the price is currently $0.53, the current price/revenue multiple has changed little since Q2 f2023 was released.
 
So, notwithstanding the dramatic improvement in "actuals", it seems the stock price is becoming more reasonable over time.  Combine that with the huge potential and you have one cheap, cheap, cheap stock.
 
Now, before someone brings up the fact that the company has, over the years, given out guidance many times and has rarely met it,  let me raise it first.  It's true and I've told the company I think they should stop giving out guidance because they're not good at estimating, at least for public consumption.  
 
In summary, you can easily see from the "actuals" above and the potential provided in my earlier posting, that this investment is quite compelling.  Most of the negative posters are quite emotional.  It's hard to be analytical when in that state.

longerterm1 wrote: Hilarious blue sky projections of which have been going on for a number of years here with nothing but huge disappointment and B.S from Reliq's dream world ceo and puppets!
Please stop typing this garbage only to suck in new inexperienced investors!
The only thing that matters is actual revenue and earnings growth!!!!
Do you really think you'll be a stock master if this does finally come true or winning on a lottery ticket????


<< Previous
Bullboard Posts
Next >>